Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Lucentis

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lucentis was produced by Novartis and Roche.

Bayer to challenge Avastin legal ruling

Bayer to challenge Avastin legal ruling

age-related macular degeneration (wet AMD) in place of two licensed but much more expensive treatments, Bayer’s Eylea and Novartis’ Lucentis. ... carried out to establish its equivalence in safety and efficacy with Lucentis in particular.

After Lucentis setback, Novartis trumpets data on follow-up drug

After Lucentis setback, Novartis trumpets data on follow-up drug of Lucentis and Eylea for AMD, even though Avastin isn’t approved for the indication. ... The US patents on Lucentis and Eylea will both expire in 2020, and in 2022 for Lucentis and 2021 for Eylea in Europe.

NHS wins legal fight with pharma over off-label Avastin

NHS wins legal fight with pharma over off-label Avastin and Novartis’ Lucentis  to treat wet AMD, claiming that it broke EU and UK laws governing medicines licensing. ... The cost implications are clear, as the court judgement showed: it says Avastin’s list price is around £28 per injection; Eylea

Allergan’s abicipar matches AMD blockbuster Lucentis in phase III

Allergan’s abicipar matches AMD blockbuster Lucentis in phase III Allergan and partner Molecular Partners say a pair of two studies of abicipar show that the drug is non-inferior to monthly dosing with Roche and Novartis’ blockbuster Lucentis (ranibizumab) when ... The new drug could halve the number of injections

Regeneron’s Dupixent and Praluent falls short

Regeneron’s Dupixent and Praluent falls short momentum. Eylea is already fending off pressure from Novartis’ Lucentis (ranibizumab) but faces more competition in the market from late-stage experimental drugs such as Novartis’ RTH258, as well as biosimilars ... of Lucentis.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics